hydroxyurea has been researched along with masoprocol in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 1 (8.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Ester, K; Hadjipavlou-Litina, D; Kralj, M; Perković, I; Pontiki, E; Simunović, M; Zorc, B | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Grisham, MB; Keenan, CM; Vaananen, PM; Wallace, JL | 1 |
| DeSesso, JM; Goeringer, GC | 1 |
| McKinney, M; Pfenning, M; Richelson, E | 1 |
| Kasiske, BL; Keane, WF; Kim, Y; O'Donnell, MP | 1 |
| Bell, RL; Brooks, CD; Huang, R; Hulkower, KI; Otis, ER; Pollock, JS; Walsh, RE | 1 |
| Hardy, DB; Pereria, LE; Yang, K | 1 |
| Donoghue, DJ; McAndrew, CW; Meyer, AN | 1 |
| Funk, CD; Nair, DG | 1 |
12 other study(ies) available for hydroxyurea and masoprocol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Urea and carbamate derivatives of primaquine: synthesis, cytostatic and antioxidant activities.
Topics: Antimalarials; Antioxidants; Biphenyl Compounds; Carbamates; Cell Line, Tumor; Cell Proliferation; Cytostatic Agents; Glycine max; Humans; Lipid Peroxidation; Lipoxygenase; Molecular Structure; Picrates; Primaquine; Urea | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Pharmacological investigation of the role of leukotrienes in the pathogenesis of experimental NSAID gastropathy.
Topics: 5-Lipoxygenase-Activating Proteins; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Benzopyrans; Carrier Proteins; Free Radical Scavengers; Gastric Mucosa; Hydroxyurea; Indoles; Indomethacin; Leukotriene Antagonists; Leukotriene B4; Leukotrienes; Lipoxygenase Inhibitors; Male; Masoprocol; Membrane Proteins; Organic Chemicals; Permeability; Phenylcarbamates; Propionates; Quinolines; Rats; Rats, Inbred Strains; Receptors, Immunologic; Receptors, Leukotriene; Receptors, Leukotriene B4; Single-Blind Method; Stomach Ulcer; Sulfonamides; Tetrazoles; Tosyl Compounds | 1992 |
Ethoxyquin and nordihydroguaiaretic acid reduce hydroxyurea developmental toxicity.
Topics: Abnormalities, Drug-Induced; Animals; Antioxidants; Body Weight; Embryo, Mammalian; Ethoxyquin; Female; Hydroxyurea; Masoprocol; Pregnancy; Rabbits | 1990 |
Effect of the antitumor drug caracemide on the neurochemistry of murine neuroblastoma cells (clone N1E-115).
Topics: Adenylyl Cyclase Inhibitors; Alprostadil; Animals; Antineoplastic Agents; Catechols; Cell Line; Cholinesterase Inhibitors; Cyclic GMP; Dithiothreitol; Dose-Response Relationship, Drug; Guanylate Cyclase; Hydroxyurea; Masoprocol; Mice; Monoamine Oxidase Inhibitors; Nervous System; Neuroblastoma; Receptors, Muscarinic | 1986 |
Oxidative modification of low-density lipoproteins by mesangial cells.
Topics: Antioxidants; Arachidonic Acid; Butylated Hydroxytoluene; Catalase; Cell Division; Cells, Cultured; Cyclooxygenase Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Deferoxamine; DNA Replication; Glomerular Mesangium; Glomerulosclerosis, Focal Segmental; Humans; Hydroxyurea; Indomethacin; Ketoconazole; Lipoproteins, LDL; Lipoxygenase Inhibitors; Masoprocol; Oxidation-Reduction; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances | 1993 |
Leukotrienes do not regulate nitric oxide production in RAW 264.7 macrophages.
Topics: Animals; Cells, Cultured; Dexamethasone; Dose-Response Relationship, Drug; Gene Expression Regulation; Hydroxyurea; Interferon-gamma; Leukotriene B4; Leukotrienes; Lipopolysaccharides; Lipoxygenase Inhibitors; Macrophages; Masoprocol; Mice; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Second Messenger Systems; Toxicity Tests | 1996 |
Prostaglandins and leukotriene B4 are potent inhibitors of 11beta-hydroxysteroid dehydrogenase type 2 activity in human choriocarcinoma JEG-3 cells.
Topics: 11-beta-Hydroxysteroid Dehydrogenases; Choriocarcinoma; Dinoprost; Dinoprostone; Enzyme Inhibitors; Humans; Hydroxysteroid Dehydrogenases; Hydroxyurea; Indomethacin; Isoenzymes; Leukotriene B4; Lipoxygenase Inhibitors; Masoprocol; Placenta; Prostaglandins; Tumor Cells, Cultured | 1999 |
Nordihydroguaiaretic acid inhibits an activated fibroblast growth factor receptor 3 mutant and blocks downstream signaling in multiple myeloma cells.
Topics: Apoptosis; Cell Line, Tumor; Fibroblast Growth Factor 2; Golgi Apparatus; Humans; Hydroxyurea; Lipoxygenase Inhibitors; Masoprocol; Multiple Myeloma; Phosphorylation; Receptor, Fibroblast Growth Factor, Type 3; Signal Transduction; Thanatophoric Dysplasia; Transfection | 2008 |
A cell-based assay for screening lipoxygenase inhibitors.
Topics: Acetamides; Cell Line; Drug Evaluation, Preclinical; Fluorenes; Humans; Hydroxyurea; Inhibitory Concentration 50; Lipoxygenase; Lipoxygenase Inhibitors; Masoprocol; Microscopy, Fluorescence; Phenyl Ethers | 2009 |